Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 429

1.

Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.

Saad RS, Cho P, Silverman JF, Liu Y.

Am J Clin Pathol. 2004 Sep;122(3):421-7.

PMID:
15362373
[PubMed - indexed for MEDLINE]
Free Article
2.
3.

Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.

Shah RN, Badve S, Papreddy K, Schindler S, Laskin WB, Yeldandi AV.

Hum Pathol. 2002 Sep;33(9):915-20.

PMID:
12378517
[PubMed - indexed for MEDLINE]
4.
5.

Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.

Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.

Cancer. 2001 Oct 25;93(5):330-6.

PMID:
11668468
[PubMed - indexed for MEDLINE]
6.
7.

[Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].

Zou SM, Lin DM, Lü N, Liu XY, Wen P, Liu FS.

Zhonghua Yi Xue Za Zhi. 2003 Aug 10;83(15):1350-2. Chinese.

PMID:
12930693
[PubMed - indexed for MEDLINE]
8.

CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.

Mazziotta RM, Borczuk AC, Powell CA, Mansukhani M.

Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):55-60.

PMID:
15722794
[PubMed - indexed for MEDLINE]
9.

Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.

McCluggage WG, Shah R, Connolly LE, McBride HA.

Int J Gynecol Pathol. 2008 Jan;27(1):92-100.

PMID:
18156982
[PubMed - indexed for MEDLINE]
10.

Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.

Tot T.

Med Sci Monit. 2004 May;10(5):BR139-43. Epub 2004 Apr 28.

PMID:
15114262
[PubMed - indexed for MEDLINE]
11.

The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.

Groisman GM, Meir A, Sabo E.

Int J Gynecol Pathol. 2004 Jan;23(1):52-7.

PMID:
14668551
[PubMed - indexed for MEDLINE]
12.

[Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].

Wang CL, Yue DS, Zhang ZF, Zhan ZL, Sun LN.

Zhonghua Yi Xue Za Zhi. 2007 Sep 4;87(33):2350-4. Chinese.

PMID:
18036300
[PubMed - indexed for MEDLINE]
13.

Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.

Cai YC, Banner B, Glickman J, Odze RD.

Hum Pathol. 2001 Oct;32(10):1087-93.

PMID:
11679943
[PubMed - indexed for MEDLINE]
14.

CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.

Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.

Jpn J Clin Oncol. 2010 Mar;40(3):208-13. doi: 10.1093/jjco/hyp150. Epub 2009 Nov 18.

PMID:
19926591
[PubMed - indexed for MEDLINE]
Free Article
15.

Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.

Su YC, Hsu YC, Chai CY.

Kaohsiung J Med Sci. 2006 Jan;22(1):14-9.

PMID:
16570563
[PubMed - indexed for MEDLINE]
16.

Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.

Leite KR, Mitteldorf CA, Srougi M, Dall'oglio MF, Antunes AA, Pontes J Jr, Camara-Lopes LH.

Ann Diagn Pathol. 2008 Aug;12(4):260-6. doi: 10.1016/j.anndiagpath.2007.11.001. Epub 2008 Apr 18.

PMID:
18620992
[PubMed - indexed for MEDLINE]
17.

CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens.

Tanaka S, Saito K, Ito T, Tajima K, Mogi A, Shitara Y, Sano T, Kuwano H.

Oncol Rep. 2007 Jul;18(1):87-92.

PMID:
17549351
[PubMed - indexed for MEDLINE]
18.

The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.

Tot T.

Cancer. 2001 Nov 15;92(10):2727-32.

PMID:
11745209
[PubMed - indexed for MEDLINE]
19.

Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma.

Ortiz-Rey JA, Alvarez C, San Miguel P, Iglesias B, Antón I.

Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):142-6.

PMID:
15894926
[PubMed - indexed for MEDLINE]
20.

Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.

Harlamert HA, Mira J, Bejarano PA, Baughman RP, Miller MA, Whitsett JA, Yassin R.

Acta Cytol. 1998 Nov-Dec;42(6):1382-8.

PMID:
9850647
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk